Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04343144 |
|---|---|
| Brief Title: | Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort. (CORIMUNO-NIVO) |
| First Submitted : | April 9, 2020 |
| First Submitted that Met QC Criteria : | April 9, 2020 |
| First Posted : | April 13, 2020 |
| Last Update Submitted that Met QC Criteria : | April 12, 2020 |
| Last Update Posted : | April 14, 2020 |